Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation

World Journal of Gastroenterology

Volumn 15, Issue 32, 2009, Pages 4067-4069

  Krygier, Darin S ^a   Steinbrecher, Urs P ^a   Petric, Martin ^b   Erb, Siegfried R ^a   Chung, Stephen W ^a   Scudamore, Charles H ^a   Buczkowski, Andrzej K ^a   Yoshida, Eric M ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Fulminant hepatic failure; Fulminant hepatitis; Orthotopic liver transplant; Parvovirus B19

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; EPSTEIN BARR VIRUS ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEPATITIS A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; ASCITES; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER TRANSPLANTATION; PARVOVIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; VIRUS DETECTION;

EID: 70949083087     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.4067     Document Type: Article

References (12)

1. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597
2. Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998; 24: 375-401 (Pubitemid 28256644)
3. So K, Macquillan G, Garas G, Delriviere L, Mitchell A, Speers D, Mews C, Augustson B, de Boer WB, Baker D, Jeffrey GP. Urgent liver transplantation for acute liver failure due to parvovirus B19 infection complicated by primary Epstein-Barr virus and cytomegalovirus infections and aplastic anaemia. Intern Med J 2007; 37: 192-195
4. Díaz F, Collazos J. Hepatic dysfunction due to parvovirus B19 infection. J Infect Chemother 2000; 6: 63-64 (Pubitemid 30241869)
5. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transpl 2008; 14: 1100-1106
6. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 1995; 22: 1661-1665
7. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 1999; 144: 1713-1724 (Pubitemid 29490033)
8. Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM, Krajden M, Yoshida EM. Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis. Can J Gastroenterol 2005; 19: 161-162
9. Tsuda H. Liver dysfunction caused by parvovirus B19. Am J Gastroenterol 1993; 88: 1463 (Pubitemid 23259536)
10. Pardi DS, Romero Y, Mertz LE, Douglas DD. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: a report of two cases and a review of the literature. Am J Gastroenterol 1998; 93: 468-470 (Pubitemid 29068361)
11. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347: 868-869 (Pubitemid 26099540)
12. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 2003; 187: 1581-1586